《半日總結》恆指升28點 醫藥及濠賭股漲 內房逆市挫
中央政治局會議指明年要優化疫情防控措施,擴內需且推進對外開放,港股早市反覆靠穩。恆指低開60點,早段曾跌108點一度低見19,332點,其後曾高見19,600點一度升158點,半日升28點或0.15%,報19,469點;國指升15點或0.2%,報6,668點;恆生科技指數升57點或1.4%,報4,218點。大市半日成交總額903.01億元,滬、深港通南下交易半日分別淨流入6.34億及9.45億元人民幣。
廣州建議非緊急就醫選擇互聯網醫院等就診,阿里健康(00241.HK)及平安好醫生(01833.HK)各升8.3%及7.1%。康方生物(09926.HK)與SummitTherapeutics達成許可協議,以開發實驗性腫瘤藥,股價抽升24.1%。其他醫藥股受帶動,康哲(00867.HK)及長江生命科技(00775.HK)抽升20.3%及21.4%,國藥(01099.HK)及康希諾(06185.HK)各升6.7%及5.1%,綠葉製藥(02186.HK)升4.2%。
其餘科技股方面,阿里巴巴(09988.HK)平收報89.85元,騰訊(00700.HK)及美團(03690.HK)各升0.4%及0.6%,百度(09888.HK)升1.4%。小米(01810.HK)及京東(09618.HK)各跌1.1%及0.8%,網易(09999.HK)跌0.3%,快手(01024.HK)及嗶哩嗶哩(09626.HK)各升3.9%及3.6%,新東方在線(01797.HK)及中芯(00981.HK)各升3.6%及3.7%。商湯(00020.HK)及易鑫(02858.HK)各炒升16%及13.4%,美圖(01357.HK)升40.8%。
澳門冀稍後可開放港澳通關,濠賭股美高梅中國(02282.HK)升9.3%,新濠國際(00200.HK)、澳博(00880.HK)及永利澳門(01128.HK)各升6.3%至7%,銀娛(00027.HK)及金沙中國(01928.HK)各升2.9%及3.8%。市場關注內地放寬新冠防控,海底撈(06862.HK)、呷哺呷哺(00520.HK)、阿里影業(01060.HK)及頤海(01579.HK)各升5.5%至6.1%,百勝中國(09987.HK)及貓眼娛樂(01896.HK)各升3.4%及4.9%。內地航空股東航(00670.HK)、國航(00753.HK)及南航(01055.HK)各升逾4%。
電動車及相關股造好,理想(02015.HK)、小鵬(09868.HK)及零跑(09863.HK)各升4.1%至4.9%,比亞迪(01211.HK)升5.7%報211元。
內房股碧桂園(02007.HK)折讓14.8%配股淨籌逾47億元,股價跌9.8%報2.86元。同業龍湖(00960.HK)跌6.7%,富力(02777.HK)、遠洋(03377.HK)及合景泰富(01813.HK)各跌4.6%至5.8%。金融股方面,匯控(00005.HK)跌0.3%報47.2元,港交所(00388.HK)升1%報333.4元,友邦(01299.HK)跌0.7%報83.6元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.